LODOCO (colchicine, 0.5 mg tablet) Reduces Cardiac Event Risk in Adult Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) by an Additional 31% on Top of Standard of Care
News | Pharmaceuticals
U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

June 20, 2023 — AGEPHA Pharma USA, LLC, announced that, following a Priority Review, the U.S. Food and Drug ...

Home June 20, 2023
Home
News | Artificial Intelligence
Advanced Medical Algorithm-based Chatbot, Pāṇini, Revolutionizes Clinical Outcomes

June 20, 2023 — Pāṇini, an AI-powered chatbot developed by doctors for doctors, has officially launched, aiming to ...

Home June 20, 2023
Home
Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts.
News | Coronavirus (COVID-19)
One Month of COVID-19 Lockdown Cost Heart Attack Patients Up to Two Years of Life

June 19, 2023 — Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to ...

Home June 19, 2023
Home
Luscii Virtual Heart Clinic aims to provide cardiologists with a comprehensive, easy-to-use app to offer remote cardiac patient monitoring to their patients. The app prompts patients to take measurements of vital signs which are automatically analysed to detect abnormalities.
News | ECG
AliveCor Collaborates with European Market Leader in Remote Patient Monitoring Luscii to Offer World's First 'Virtual Heart Clinic in a Box'

June 19, 2023 — AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking ...

Home June 19, 2023
Home
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).
News | Peripheral Artery Disease (PAD)
Endologix Announces 24-Month Results of DETOUR- 2 Study at 2023 Vascular Annual Meeting

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
Out-of-hospital cardiac arrests (OCHA) cause significant mortality and morbidity, and the study is one the largest trials ever conducted on cardiac arrest patients admitted to intensive care units (ICU).
News | Cardiovascular Clinical Studies
New Data from Global TAME Study Supports Current Management of CO2 Levels in Cardiac Arrest Patients

June 16, 2023 — A promising emerging treatment (hypercapnia) for comatose adult cardiac arrest patients has been found ...

Home June 16, 2023
Home
News | Cardiovascular Clinical Studies
Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023

June 16, 2023 — Esperion presented results from an analysis comparing the cardiovascular risk reduction benefits of ...

Home June 16, 2023
Home
Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.
News | Cardiac Imaging
Dr. Jonathan Weinsaft Named Chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center

June 15, 2023 — Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and ...

Home June 15, 2023
Home
Kandu Health is working to fulfill an urgent need in healthcare by supporting stroke patients beyond the hospital through a team of clinically licensed navigators, community support groups, and an easy-to-use app.
News | Cardiovascular Clinical Studies
Kandu Health Achieves Successful Enrollment of the First 50 Stroke Survivors in its Stroke Recovery Program, Appoints New Leadership

June 15, 2023 — Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and ...

Home June 15, 2023
Home
Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).
News | Peripheral Artery Disease (PAD)
Endologix Receives FDA Approval of the DETOUR System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

Home June 15, 2023
Home
A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain.
News | Coronavirus (COVID-19)
New Imaging Technique Captures COVID-19’s Impact on the Brain

June 14, 2023 — A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies ...

Home June 14, 2023
Home
NIH-supported study could lead to less restrictions for those with hypertrophic cardiomyopathy
News | Cardiovascular Clinical Studies
Vigorous Exercise Not Tied to Increased Risk of Adverse Events in Rare Heart Condition

June 14, 2023 — Vigorous exercise does not appear to increase the risk of death or life-threatening arrhythmia for ...

Home June 14, 2023
Home
The OCEANIC-AF (atrial fibrillation) study with asundexian is part of the Phase III OCEANIC clinical trial program enrolling more than 27,000 patients in over 40 countries
News | Stroke
Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program

June 14, 2023 — Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ...

Home June 14, 2023
Home
Novel polymeric valve aims to reduce re-operations and re-interventions
News | Pediatric Cardiology
PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S. Clinical Trial

June 13, 2023 — PECA Labs, a medical device company reimagining vascular grafts and valves with durable polymeric ...

Home June 13, 2023
Home
The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease
News | Stents
Gore Initiates Study to Compare the Gore Viabahn VBX Balloon Expandable Endoprosthesis to Bare Metal Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...

Home June 13, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now